WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals International PLC Stock Ownership - Who owns Kiniksa Pharmaceuticals International?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kiniksa Pharmaceuticals International PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eben TessariCHIEF OPERATING OFFICER2025-06-166,500$8.83
$57.40kBuy
Eben TessariCHIEF OPERATING OFFICER2025-06-1617,300$28.28
$489.24kSell
Barry D. QuartDirector2025-06-1112,336$3.80
$46.88kBuy
Barry D. QuartDirector2025-06-1112,336$30.39
$374.89kSell
Eben TessariCHIEF OPERATING OFFICER2025-06-1145,042$30.51
$1.37MSell
Eben TessariCHIEF OPERATING OFFICER2025-06-1145,042$10.36
$466.64kBuy
Barry D. QuartDirector2025-06-108,212$30.36
$249.32kSell
Eben TessariCHIEF OPERATING OFFICER2025-06-1015,506$30.46
$472.31kSell
Eben TessariCHIEF OPERATING OFFICER2025-06-1015,506$10.36
$160.64kBuy
Barry D. QuartDirector2025-06-108,212$3.80
$31.21kBuy

1 of 18

KNSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KNSA insiders and whales buy or sell their stock.

KNSA Shareholders

What type of owners hold Kiniksa Pharmaceuticals International PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc4.70%3,432,699$95.94MInstitution
Rubric Capital Management LP4.64%3,383,239$94.56MInstitution
Vanguard Group Inc4.60%3,359,101$93.89MInstitution
Baker Bros Advisors LP3.86%2,818,323$78.77MInstitution
Baker Bros Advisors LP3.77%2,753,656$76.96MInsider
Tang Capital Management LLC2.90%2,118,579$59.21MInstitution
Braidwell LP2.69%1,962,909$54.86MInstitution
Cormorant Asset Management LP2.37%1,731,442$48.39MInsider
James E. Flynn1.68%1,226,890$34.29MInsider
Point72 Asset Management LP1.58%1,149,411$32.13MInstitution

1 of 3

KNSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KNSA54.78%9.64%Net SellingNet Selling
CGON88.05%11.95%Net SellingNet Buying
VCEL91.20%8.80%Net SellingNet Buying
BEAM84.84%15.16%Net SellingNet Selling
FOLD65.78%34.22%Net Selling
View Top Biotech Stocks

Kiniksa Pharmaceuticals International Stock Ownership FAQ

Who owns Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is owned by 54.78% institutional shareholders, 9.64% Kiniksa Pharmaceuticals International insiders, and 35.59% retail investors. Baker Bros Advisors LP is the largest individual Kiniksa Pharmaceuticals International shareholder, owning 2.75M shares representing 3.77% of the company. Baker Bros Advisors LP's Kiniksa Pharmaceuticals International shares are currently valued at $74.93M.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals International stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.